When Waud Capital Partners closed Fund IV at $1.056 billion in Feb. 2016, the firm held eight active portfolio companies. LPs weren’t just buying a management team and a thesis, they were buying into a live portfolio that reflected the firm’s execution to date.
A snapshot of those holdings revealed why the fund oversubscribed 41% above target in 12 weeks.
Healthcare Holdings
Acadia Healthcare (NASDAQ: ACHC) anchored the portfolio. Reeve Waud founded the company in 2005 as a behavioral health startup. WCP backed it through rapid expansion and a 2011 IPO. By early 2016, Acadia had grown into one of the nation’s largest behavioral health operators, with more than 200 facilities. Reeve B. Waud continued serving as Chairman of Acadia’s board (Acadia Healthcare).
Center for Vein Restoration had recently exited, growing from 11 clinics to 44 clinics across eight states under WCP’s four-year ownership. CVR’s CEO called Waud Capital “a tremendous partner” who “shared my vision of building a first-class vein treatment business.” Additional healthcare investments rounded out the portfolio.
Business Services and Technology
CyberGrants, based in Andover, Massachusetts, offered corporate philanthropic software. Pilot Thomas Logistics, headquartered in Fort Worth, Texas, operated in petroleum and lubricant distribution. Together with the firm’s healthcare companies, the eight active holdings gave LPs exposure across two distinct sectors (Crain’s Chicago Business).
Reeve Waud and his team had completed 185+ total investments by Fund IV’s close, spanning platform acquisitions and add-ons since 1993 (PE Professional). The mix of public (Acadia) and private holdings offered LPs both liquidity and growth optionality. WCP IV’s $50-$100 million equity check size placed the firm squarely in the middle-market sweet spot where operational improvement drives returns, not financial engineering.
